Ramos et al. (2018) conducted an in vivo study comparing the third-generation CD19-specific CAR-T cells with second-generation CD19-specific CAR-T cells in B cell non-Hodgkin’s lymphomas. The gene discussed is CD19; the disease is B-cell non-Hodgkin lymphoma.